his is the fifth year of competition for the New Investigator Awards in Arteriosclerosis, Thrombosis, and Vascular Biology. The awards recognize articles published in Arteriosclerosis, Thrombosis, and Vascular Biology in 2009 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis/Lipoprotein, Thrombosis, and Vascular Biology sections of the journal. The 3 awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling.
In the fifth year of the award, 655 articles were submitted for the awards. The recipients will be honored at the 11th Annual Conference on Atherosclerosis, Thrombosis, and Vascular Biology; and will receive a plaque, travel support (provided by the Arteriosclerosis, Thrombosis, and Vascular Biology Council), and a check for $2500, provided by Lippincott, Williams & Wilkins.
The editors congratulate the recipients of the awards for their outstanding articles!
